| Robert Blaine Kolbe Jr, MD | |
|
1144 W Plymouth St, Bremen, IN 46506-1842 | |
| (574) 546-5363 | |
| (574) 546-2575 |
| Full Name | Robert Blaine Kolbe Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 1144 W Plymouth St, Bremen, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639118839 | NPI | - | NPPES |
| 000000215338 | Other | IN | BCBS |
| 000000513302 | Other | IN | BCBS |
| 100358240 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01031578 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital Of Bremen Inc | Bremen, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
Helix BioPharma announced today the opening of two additional German sites for the Phase II clinical trial of its Topical Interferon Alpha-2b product at the Charité Berlin, one of the largest university hospitals in Europe.
Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation. However, prolonged use raises the risk of heart and kidney failure events. A heart attack causes death of heart muscle cells by lack of oxygen, and it also significantly injures the kidneys.
Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, today reported results for the second quarter ended June 30, 2010. Net sales for the quarter were $968 million, and adjusted diluted earnings per share were $0.86.
Taking opioids prior to reverse shoulder arthroplasty does not hamper patients' chances of having successful outcomes, researchers have found.
› Verified 1 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
Helix BioPharma announced today the opening of two additional German sites for the Phase II clinical trial of its Topical Interferon Alpha-2b product at the Charité Berlin, one of the largest university hospitals in Europe.
Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation. However, prolonged use raises the risk of heart and kidney failure events. A heart attack causes death of heart muscle cells by lack of oxygen, and it also significantly injures the kidneys.
Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, today reported results for the second quarter ended June 30, 2010. Net sales for the quarter were $968 million, and adjusted diluted earnings per share were $0.86.
Taking opioids prior to reverse shoulder arthroplasty does not hamper patients' chances of having successful outcomes, researchers have found.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Blaine Kolbe Jr, MD 3245 Health Dr Ste 100, Granger, IN 46530-1380 Ph: () - | Robert Blaine Kolbe Jr, MD 1144 W Plymouth St, Bremen, IN 46506-1842 Ph: (574) 546-5363 |
News Archive
Helix BioPharma announced today the opening of two additional German sites for the Phase II clinical trial of its Topical Interferon Alpha-2b product at the Charité Berlin, one of the largest university hospitals in Europe.
Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation. However, prolonged use raises the risk of heart and kidney failure events. A heart attack causes death of heart muscle cells by lack of oxygen, and it also significantly injures the kidneys.
Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, today reported results for the second quarter ended June 30, 2010. Net sales for the quarter were $968 million, and adjusted diluted earnings per share were $0.86.
Taking opioids prior to reverse shoulder arthroplasty does not hamper patients' chances of having successful outcomes, researchers have found.
› Verified 1 days ago
Dr. Michael R Mcclaid, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1724 W Plymouth St, Bremen, IN 46506 Phone: 574-546-3045 Fax: 574-546-2716 | |
Keyna Ann Martinez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1144 W Plymouth St, Bremen, IN 46506 Phone: 574-546-5363 Fax: 574-546-2575 | |
Frank A. Snyder, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1724 W Plymouth St, Bremen, IN 46506 Phone: 574-546-3045 Fax: 574-546-2716 | |
David M. Rosentrater, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1724 W Plymouth St, Bremen, IN 46506 Phone: 574-546-3045 Fax: 574-546-2716 | |
Gregory Edward Buck, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1144 W Plymouth St, Bremen, IN 46506 Phone: 574-546-5363 Fax: 574-546-2575 | |
Dr. John Robert Larson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1724 W Plymouth St, Bremen, IN 46506 Phone: 574-546-3649 Fax: 574-546-3952 | |
Mrs. Laura A Both, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1144 W. Plymouth St., Bremen, IN 46506 Phone: 574-546-5363 Fax: 574-546-2575 |